|
?:authorAffiliation
|
-
[\'Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.\', \'WSCollaborative, McLean, Virginia, USA.\', \'National Brain Tumor Society, Newton, Massachusetts, USA.\', \'Edison Oncology Holding Corp., Menlo Park, California, USA.\', \'Office of Hematology and Oncology Products at the Food and Drug Administration, Silver Spring, Maryland, USA.\', \'Office of Biostatistics, Center for Drug Evaluation and Research at the Food and Drug Administration, Silver Spring, Maryland, USA.\', \'Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.\', \'Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.\', \'Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.\', \'Agios Pharmaceuticals, Cambridge, Massachusetts, USA.\', \'Bayer Pharmaceuticals, Hillsborough, New Jersey, USA.\', \'Preston Robert Tisch Brain Tumor Center at Duke, Departments of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA.\', \'Department of Dermatology at Massachusetts General Hospital, Boston, Massachusetts, USA.\', \'Department of Neurology and Herbert Irving Comprehensive Cancer Center, New-York Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, USA.\', \'Department of Neuro-Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.\', \'Department of Neurology at Massachusetts General Hospital, Boston, Massachusetts, USA.\', \'Karyopharm Therapeutics, Inc., Newton, Massachusetts, USA.\', \'MacFeeters-Hamilton Center for Neuro-Oncology, Princess Margaret Cancer Center, Toronto, Ontario, Canada.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}